Zentiva S.A. engages in the production and marketing of preparations and medicines for human use in Romania and internationally. The company develops pharmaceutical products in various therapeutic areas, such as cardiovascular diseases, anti-inflammatory and pain-relieving medications, urologists, blood diseases, gastrointestinal and metabolic disorders, central nervous system, infections, respiratory systems, and other, as well as develops generic medicines. It also offers educational materials for healthcare professionals and patients. The company was formerly known as Sicomed S.A. and changed its name to Zentiva S.A. in January 2006. The company was founded in 1962 and is based in Bucharest, Romania. Zentiva S.A. is a subsidiary of Zentiva Group a.s.
Frequently asked questions
What sector does ZENTIVA S.A. (SCD) operate in?
ZENTIVA S.A. belongs to the Other sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is ZENTIVA S.A. (SCD) current stock price?
As of the latest data, ZENTIVA S.A. stock price is RON 4.52, with a previous close of RON 4.52.
What is ZENTIVA S.A. (SCD) current market capitalization?
ZENTIVA S.A. market cap is approximately 3.15 billion.
What is ZENTIVA S.A. (SCD) Earnings Per Share (EPS)?
The trailing EPS is RON 0.39.
What is ZENTIVA S.A. (SCD) Price-to-Earnings (P/E) ratio?
ZENTIVA S.A. current P/E ratio is 11.59.
Does ZENTIVA S.A. (SCD) pay dividends?
No. ZENTIVA S.A. does not pay a dividend.
What is ZENTIVA S.A. (SCD) beta (volatility) score?
ZENTIVA S.A. has a beta of 0.245, indicating lower volatility than the overall market.
